ALNYLAM PHARMACEUTICALS, INC. (ALNY) Gross margin 2017–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) gross margin by fiscal year — reported gross profit divided by reported revenue.
81.8%FY2025 · since FY2017: 100.0% → 81.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 81.8% | -4.6 pp |
| FY2024 | 86.4% | +1.0 pp |
| FY2023 | 85.3% | -1.2 pp |
| FY2022 | 86.5% | +0.1 pp |
| FY2021 | 86.4% | +1.4 pp |
| FY2020 | 84.9% | -3.6 pp |
| FY2019 | 88.6% | -9.0 pp |
| FY2018 | 97.6% | -2.4 pp |
| FY2017 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice